Resources

Case studies

“Ultra High” Potency Development and Manufacture

Cambrex was approached by a US-based biotechnology company to develop a process for producing a highly potent API, a DNA alkylator, used to treat an unmet oncology need.

Adapting to change – API custom development and manufacturing case study

Cambrex was approached by a top 100 European-based pharmaceutical company looking for a development and manufacturing partner to assist with an in-licensed product originating from an emerging pharma company.

Speed to market – API large scale commercial manufacturing case study

Cambrex was approached by a top 20 US-based pharmaceutical company looking to partner with a contract manufacturing organization (CMO) with commercial manufacturing capabilities, large scale assets, multinational sites and exemplary quality systems/US FDA track record.

Investing in capacity – API commercial manufacturing case study

Cambrex was approached by a top 10 Asian pharmaceutical company looking to partner with a contract manufacturing organization (CMO) with commercial manufacturing capabilities and expertise, mid- to large-scale cGMP assets and exemplary quality systems and US FDA track record.